Your browser doesn't support javascript.
loading
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts.
Oelofse, S; Esmail, A; Diacon, A H; Conradie, F; Olayanju, O; Ngubane, N; Howell, P; Everitt, D; Crook, A M; Mendel, C M; Wills, G H; Olugbosi, M; Del Parigi, A; Sun, E; Calatroni, A; Spigelman, M; Dheda, K.
Afiliación
  • Oelofse S; Centre for Lung Infection and Immunity, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town (UCT), Cape Town, South Africa.
  • Esmail A; Centre for Lung Infection and Immunity, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town (UCT), Cape Town, South Africa.
  • Diacon AH; Task Applied Science and Stellenbosch University, Cape Town, South Africa.
  • Conradie F; Clinical HIV Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa, Sizwe Tropical Disease Hospital, Sandringham, South Africa.
  • Olayanju O; Centre for Lung Infection and Immunity, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town (UCT), Cape Town, South Africa.
  • Ngubane N; Task Applied Science and Stellenbosch University, Cape Town, South Africa, King DinuZulu Hospital Complex, Durban, South Africa.
  • Howell P; Clinical HIV Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa, Sizwe Tropical Disease Hospital, Sandringham, South Africa.
  • Everitt D; TB Alliance, New York, NY, USA.
  • Crook AM; Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Mendel CM; TB Alliance, New York, NY, USA.
  • Wills GH; Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Olugbosi M; TB Alliance, Pretoria, South Africa.
  • Del Parigi A; TB Alliance, New York, NY, USA.
  • Sun E; TB Alliance, New York, NY, USA.
  • Calatroni A; Rho Federal Systems Division, Inc., Durham, NC, USA.
  • Spigelman M; TB Alliance, New York, NY, USA.
  • Dheda K; Centre for Lung Infection and Immunity, Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town (UCT), Cape Town, South Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Faculty of Infectious and
Int J Tuberc Lung Dis ; 25(6): 453-460, 2021 06 01.
Article en En | MEDLINE | ID: mdl-34049607
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Tuberculosis Extensivamente Resistente a Drogas Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2021 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Tuberculosis Extensivamente Resistente a Drogas Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2021 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Francia